Interim observations on benefit/risk of azathioprine versus D-penicillamine in the treatment of rheumatoid arthritis.
AUTOR(ES)
Ward, J R
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1030288Documentos Relacionados
- D-penicillamine withdrawal in rheumatoid arthritis.
- Pure red cell aplasia caused by D-penicillamine treatment of rheumatoid arthritis.
- Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.
- A biochemical comparison of alclofenac and D-penicillamine in rheumatoid arthritis.
- Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.